Please assess the completion status of the following clinical trial:

Trial Title: Automatized Semi-Whole-Body-MRI Protocol for Cancer Staging

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Clinically indicated PET/CT for cancer staging or response assess-ment in patients with histopathologically confirmed solid tumors (e.g.prostate, breast, gastrointestinal, testicles)~* MRI can be scheduled within 1 week to PET/CT exam~Exclusion Criteria:~* general MRI contraindications (devices (e.g. certain pacemakers), pregnancy, claustrophobia)~* severely reduced general condition~* impaired renal function

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Oncologic patients (Type: OTHER): Oncologic patients with a previous PET/CT for whole-body staging

Based on this trial design, predict the completion outcome and termination type (if applicable).